Cancer Heterogeneity is Not Compatible with One Unique Cancer Cell Metabolic Map

Overview

Journal Oncogene

Specialties Molecular Biology
Oncology

Date 2016 Nov 1

PMID 27797377

Citations 52

Authors

A Strickaert

M Saiselet

G Dom

X De Deken

J E Dumont

O Feron

P Sonveaux

C Maenhaut

Affiliations

Soon will be listed here.

Abstract

The Warburg effect and its accompanying metabolic features (anaplerosis, cataplerosis) are presented in textbooks and reviews as a hallmark (general characteristic): the metabolic map of cancer. On the other hand, research articles on specific tumors since a few years emphasize various biological features of different cancers, different cells in a cancer and the dynamic heterogeneity of these cells. We have analysed the research literature of the subject and show the generality of a dynamic, evolving biological and metabolic, spatial and temporal heterogeneity of individual cancers. We conclude that there is no one metabolic map of cancer but several and describe the two extremes of a panel from the hypoxic to the normoxic state. The implications for the significance of general 'omic' studies, and on therapeutic conclusions drawn from them and for the diagnostic use of fractional biopsies is discussed.

Citing Articles

FABP5 is a key player in metabolic modulation and NF-κB dependent inflammation driving pleural mesothelioma.

Vecchio E, Gallo R, Mimmi S, Gentile D, Giordano C, Straface E Commun Biol. 2025; 8(1):324.

PMID: 40016284 PMC: 11868402. DOI: 10.1038/s42003-025-07754-0.

Single-cell RNA-sequencing and spatial transcriptomic analysis reveal a distinct population of APOE cells yielding pathological lymph node metastasis in papillary thyroid cancer.

Xiao G, Xie R, Gu J, Huang Y, Ding M, Shen D Clin Transl Med. 2025; 15(1):e70172.

PMID: 39810624 PMC: 11733439. DOI: 10.1002/ctm2.70172.

Unraveling the intricate relationship between lipid metabolism and oncogenic signaling pathways.

Khan F, Elsori D, Verma M, Pandey S, Rab S, Siddiqui S Front Cell Dev Biol. 2024; 12:1399065.

PMID: 38933330 PMC: 11199418. DOI: 10.3389/fcell.2024.1399065.

Adhesion, metastasis, and inhibition of cancer cells: a comprehensive review.

Yayan J, Franke K, Berger M, Windisch W, Rasche K Mol Biol Rep. 2024; 51(1):165.

PMID: 38252369 PMC: 10803487. DOI: 10.1007/s11033-023-08920-5.

Assessment of Primary Human Liver Cancer Cells by Artificial Intelligence-Assisted Raman Spectroscopy.

Esposito C, Janneh M, Spaziani S, Calcagno V, Bernardi M, Iammarino M Cells. 2023; 12(22).

PMID: 37998378 PMC: 10670489. DOI: 10.3390/cells12222645.

References

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

Friedl P, Alexander S . Cancer invasion and the microenvironment: plasticity and reciprocity. Cell. 2011; 147(5):992-1009. DOI: 10.1016/j.cell.2011.11.016. View

Andor N, Graham T, Jansen M, Xia L, Aktipis C, Petritsch C . Pan-cancer analysis of the extent and consequences of intratumor heterogeneity. Nat Med. 2015; 22(1):105-13. PMC: 4830693. DOI: 10.1038/nm.3984. View

Tarabichi M, Antoniou A, Saiselet M, Pita J, Andry G, Dumont J . Systems biology of cancer: entropy, disorder, and selection-driven evolution to independence, invasion and "swarm intelligence". Cancer Metastasis Rev. 2013; 32(3-4):403-21. PMC: 3843370. DOI: 10.1007/s10555-013-9431-y. View

Payen V, Brisson L, Dewhirst M, Sonveaux P . Common responses of tumors and wounds to hypoxia. Cancer J. 2015; 21(2):75-87. DOI: 10.1097/PPO.0000000000000098. View

Doherty J, Cleveland J . Targeting lactate metabolism for cancer therapeutics. J Clin Invest. 2013; 123(9):3685-92. PMC: 3754272. DOI: 10.1172/JCI69741. View

Warburg O, Wind F, Negelein E . THE METABOLISM OF TUMORS IN THE BODY. J Gen Physiol. 2009; 8(6):519-30. PMC: 2140820. DOI: 10.1085/jgp.8.6.519. View

Dalerba P, Kalisky T, Sahoo D, Rajendran P, Rothenberg M, Leyrat A . Single-cell dissection of transcriptional heterogeneity in human colon tumors. Nat Biotechnol. 2011; 29(12):1120-7. PMC: 3237928. DOI: 10.1038/nbt.2038. View

Malaise E, Chavaudra N, TUBIANA M . The relationship between growth rate, labelling index and histological type of human solid tumours. Eur J Cancer (1965). 1973; 9(4):305-12. DOI: 10.1016/0014-2964(73)90099-6. View

10.

Ostergaard L, Tietze A, Nielsen T, Drasbek K, Mouridsen K, Jespersen S . The relationship between tumor blood flow, angiogenesis, tumor hypoxia, and aerobic glycolysis. Cancer Res. 2013; 73(18):5618-24. DOI: 10.1158/0008-5472.CAN-13-0964. View

11.

Caillou B, Talbot M, Weyemi U, Pioche-Durieu C, Al Ghuzlan A, Bidart J . Tumor-associated macrophages (TAMs) form an interconnected cellular supportive network in anaplastic thyroid carcinoma. PLoS One. 2011; 6(7):e22567. PMC: 3141071. DOI: 10.1371/journal.pone.0022567. View

12.

Nakajima E, Van Houten B . Metabolic symbiosis in cancer: refocusing the Warburg lens. Mol Carcinog. 2012; 52(5):329-37. PMC: 9972501. DOI: 10.1002/mc.21863. View

13.

Cardenas-Navia L, Mace D, Richardson R, Wilson D, Shan S, Dewhirst M . The pervasive presence of fluctuating oxygenation in tumors. Cancer Res. 2008; 68(14):5812-9. DOI: 10.1158/0008-5472.CAN-07-6387. View

14.

Bonuccelli G, Tsirigos A, Whitaker-Menezes D, Pavlides S, Pestell R, Chiavarina B . Ketones and lactate "fuel" tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism. Cell Cycle. 2010; 9(17):3506-14. PMC: 3047616. DOI: 10.4161/cc.9.17.12731. View

15.

Fiaschi T, Giannoni E, Taddei M, Cirri P, Marini A, Pintus G . Carbonic anhydrase IX from cancer-associated fibroblasts drives epithelial-mesenchymal transition in prostate carcinoma cells. Cell Cycle. 2013; 12(11):1791-801. PMC: 3713137. DOI: 10.4161/cc.24902. View

16.

Perez-Escuredo J, Dadhich R, Dhup S, Cacace A, Van Hee V, De Saedeleer C . Lactate promotes glutamine uptake and metabolism in oxidative cancer cells. Cell Cycle. 2015; 15(1):72-83. PMC: 4825768. DOI: 10.1080/15384101.2015.1120930. View

17.

Swanton C . Intratumor heterogeneity: evolution through space and time. Cancer Res. 2012; 72(19):4875-82. PMC: 3712191. DOI: 10.1158/0008-5472.CAN-12-2217. View

18.

Vaupel P, Mayer A, Hockel M . Tumor hypoxia and malignant progression. Methods Enzymol. 2004; 381:335-54. DOI: 10.1016/S0076-6879(04)81023-1. View

19.

Metallo C, Gameiro P, Bell E, Mattaini K, Yang J, Hiller K . Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature. 2011; 481(7381):380-4. PMC: 3710581. DOI: 10.1038/nature10602. View

20.

Rankin E, Giaccia A . Hypoxic control of metastasis. Science. 2016; 352(6282):175-80. PMC: 4898055. DOI: 10.1126/science.aaf4405. View